---
schema_version: "secwatch.filing_event.v1"
accession: "0001099800-26-000048"
form_type: "8-K"
ticker: "EW"
cik: "0001099800"
company_name: "Edwards Lifesciences Corp"
filed_at: "2026-08-28T20:15:18+00:00"
generated_at: "2026-08-28T20:17:31.814805+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Edwards Lifesciences Strategy VP Donald Bobo to retire by mid-2027; successor search begins

## Summary
- Donald E. Bobo, Jr., Corporate Vice President of Strategy and Corporate Development, plans to retire by mid-year 2027.
- Board will begin a selection process promptly to identify a successor, with transition expected during 2027.
- Bobo is expected to remain as a consultant with the Company through the end of 2027.

## SEC filing metadata
- accession: 0001099800-26-000048
- form_type: 8-K
- ticker: EW
- cik: 0001099800
- company_name: Edwards Lifesciences Corp
- filed_at: 2026-08-28T20:15:18+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1099800/000109980026000048/0001099800-26-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1099800/000109980026000048/ew-20260825.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001099800-26-000048
- JSON: https://secwatch.observer/filing/0001099800-26-000048.json
- Plain text: https://secwatch.observer/filing/0001099800-26-000048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.